Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells von Lichtenegger, Felix S, Rothe, Maurine, Schnorfeil, Frauke M, Deiser, Katrin, Krupka, Christina, Augsberger, Christian, Schlüter, Miriam, Neitz, Julia, Subklewe, Marion

Volltext

Recent developments in immunotherapy of acute myeloid leukemia von Lichtenegger, Felix S, Krupka, Christina, Haubner, Sascha, Köhnke, Thomas, Subklewe, Marion

Volltext

RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade von Ruzicka, Michael, Koenig, Lars M., Formisano, Simone, Boehmer, Daniel F. R., Vick, Binje, Heuer, Eva-M., Meinl, Hanna, Kocheise, Lorenz, Zeitlhöfler, Marcus, Ahlfeld, Julia, Kobold, Sebastian, Endres, Stefan, Subklewe, Marion, Duewell, Peter, Schnurr, Max, Jeremias, Irmela, Lichtenegger, Felix S., Rothenfusser, Simon

Volltext

CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by Toll-like receptor-induced dendritic cells von Lichtenegger, Felix S, Mueller, Katharina, Otte, Bettina, Beck, Barbara, Hiddemann, Wolfgang, Schendel, Dolores J, Subklewe, Marion

Volltext

Cellular Uptake of Tile-Assembled DNA Nanotubes von Kocabey, Samet, Meinl, Hanna, MacPherson, Iain S, Cassinelli, Valentina, Manetto, Antonio, Rothenfusser, Simon, Liedl, Tim, Lichtenegger, Felix S

Volltext

Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens von Hänel, Gerulf, Angerer, Caroline, Petry, Katja, Lichtenegger, Felix S., Subklewe, Marion

Volltext

Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial von Lichtenegger, Felix S, Schnorfeil, Frauke M, Rothe, Maurine, Deiser, Katrin, Altmann, Torben, Bücklein, Veit L, Köhnke, Thomas, Augsberger, Christian, Konstandin, Nikola P, Spiekermann, Karsten, Moosmann, Andreas, Boehm, Stephan, Boxberg, Melanie, Heemskerk, Mirjam HM, Goerlich, Dennis, Wittmann, Georg, Wagner, Beate, Hiddemann, Wolfgang, Schendel, Dolores J, Kvalheim, Gunnar, Bigalke, Iris, Subklewe, Marion

Volltext

Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission von Beck, Barbara, Dörfel, Daniela, Lichtenegger, Felix S, Geiger, Christiane, Lindner, Lysann, Merk, Martina, Schendel, Dolores J, Subklewe, Marion

Volltext

T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment von Schnorfeil, Frauke M, Lichtenegger, Felix S, Emmerig, Katharina, Schlueter, Miriam, Neitz, Julia S, Draenert, Rika, Hiddemann, Wolfgang, Subklewe, Marion

Volltext

Immunotherapy for Acute Myeloid Leukemia von Lichtenegger, Felix S, Krupka, Christina, Köhnke, Thomas, Subklewe, Marion

Volltext

CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell–engaging antibody AMG 330 von Krupka, Christina, Kufer, Peter, Kischel, Roman, Zugmaier, Gerhard, Bögeholz, Jan, Köhnke, Thomas, Lichtenegger, Felix S., Schneider, Stephanie, Metzeler, Klaus H., Fiegl, Michael, Spiekermann, Karsten, Baeuerle, Patrick A., Hiddemann, Wolfgang, Riethmüller, Gert, Subklewe, Marion

Volltext

Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody von Augsberger, Christian, Hänel, Gerulf, Xu, Wei, Pulko, Vesna, Hanisch, Lydia Jasmin, Augustin, Angelique, Challier, John, Hunt, Katharina, Vick, Binje, Rovatti, Pier Eduardo, Krupka, Christina, Rothe, Maurine, Schönle, Anne, Sam, Johannes, Lezan, Emmanuelle, Ducret, Axel, Ortiz-Franyuti, Daniela, Walz, Antje-Christine, Benz, Jörg, Bujotzek, Alexander, Lichtenegger, Felix S., Gassner, Christian, Carpy, Alejandro, Lyamichev, Victor, Patel, Jigar, Konstandin, Nikola, Tunger, Antje, Schmitz, Marc, von Bergwelt-Baildon, Michael, Spiekermann, Karsten, Vago, Luca, Jeremias, Irmela, Marrer-Berger, Estelle, Umaña, Pablo, Klein, Christian, Subklewe, Marion

Volltext

MBP-PLP fusion protein-induced EAE in C57BL/6 mice von Kuerten, Stefanie, Lichtenegger, Felix S., Faas, Susan, Angelov, Doychin N., Tary-Lehmann, Magdalena, Lehmann, Paul V.

Volltext

Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1‐JAK2, BCR‐JAK2 and ETV6‐ABL1 fusion genes von Schwaab, Juliana, Naumann, Nicole, Luebke, Johannes, Jawhar, Mohamad, Somervaille, Tim C.P., Williams, Mark S., Frewin, Rebecca, Jost, Philipp J., Lichtenegger, Felix S., La Rosée, Paul, Storch, Nicola, Haferlach, Torsten, Horny, Hans‐Peter, Fabarius, Alice, Haferlach, Claudia, Burchert, Andreas, Hofmann, Wolf‐Karsten, Cross, Nicholas C.P., Hochhaus, Andreas, Reiter, Andreas, Metzgeroth, Georgia

Volltext

Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AML von Lichtenegger, Felix S, Lorenz, Robin, Gellhaus, Katharina, Hiddemann, Wolfgang, Beck, Barbara, Subklewe, Marion

Volltext

New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia von Subklewe, Marion, Geiger, Christiane, Lichtenegger, Felix S., Javorovic, Miran, Kvalheim, Gunnar, Schendel, Dolores J., Bigalke, Iris

Volltext

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia von Van Acker, Heleen H, Versteven, Maarten, Lichtenegger, Felix S, Roex, Gils, Campillo-Davo, Diana, Lion, Eva, Subklewe, Marion, Van Tendeloo, Viggo F, Berneman, Zwi N, Anguille, Sébastien

Volltext

Targeting CD157 in AML using a novel, Fc-engineered antibody construct von Krupka, Christina, Lichtenegger, Felix S, Köhnke, Thomas, Bögeholz, Jan, Bücklein, Veit, Roiss, Michael, Altmann, Torben, Do, To Uyen, Dusek, Rachel, Wilson, Keith, Bisht, Arnima, Terrett, Jon, Aud, Dee, Pombo-Villar, Esteban, Rohlff, Christian, Hiddemann, Wolfgang, Subklewe, Marion

Volltext

RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML von Lichtenegger, Felix S., Kondla, Isabell, Krempasky, Michael, Weber, Anna L., Herold, Tobias, Krupka, Christina, Spiekermann, Karsten, Schneider, Stephanie, Büchner, Thomas, Berdel, Wolfgang E., Wörmann, Bernhard J., Hiddemann, Wolfgang, Subklewe, Marion

Volltext

Targeting CD157 in AML using a novel, Fc-engineered antibody construct von Krupka, Christina, Lichtenegger, Felix S., Köhnke, Thomas, Bögeholz, Jan, Bücklein, Veit, Roiss, Michael, Altmann, Torben, Do, To Uyen, Dusek, Rachel, Wilson, Keith, Bisht, Arnima, Terrett, Jon, Aud, Dee, Pombo-Villar, Esteban, Rohlff, Christian, Hiddemann, Wolfgang, Subklewe, Marion

Volltext